Neurocrine Biosciences (NBIX) Provides Q4 Preliminary Revenue Above the Consensus - StreetInsider.com

Submitted by Anonymous (not verified) on Mon, 01/07/2019 - 11:36

Neurocrine Biosciences (NBIX) Provides Q4 Preliminary Revenue Above the Consensus  StreetInsider.comNeurocrine Biosciences, Inc. (NASDAQ: NBIX) today provided an update on its business performance, including preliminary net product sales results for 2018, ...